Literature DB >> 8189520

Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus.

B Klaver1, B Berkhout.   

Abstract

The architecture of a retroviral genome presents some unusual features for transcriptional regulation because of duplication of the transcriptional control sequences in the 5' and 3' long terminal repeats (LTRs). We have studied the transcriptional activity of the 5' and 3' LTRs of human immunodeficiency virus type 1 (HIV-1) vectors. Using full-length HIV molecular clones, we demonstrate that both LTRs function as Tat-inducible promoters. However, the absolute levels of transcription were found to be much higher for the 5' LTR than for the 3' LTR promoter. When transcription was assayed for an integrated HIV-1 provirus, we also found that the upstream 5' LTR element was the major transcriptional promoter. 3' LTR transcription, however, can be triggered by inactivation of the 5' LTR promoter. Likewise, 5' LTR transcription is induced in constructs lacking a functional 3' LTR promoter. This phenomenon of promoter suppression may have important implications for the design of HIV-based retrovirus vectors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189520      PMCID: PMC236888     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

Authors:  A I Dayton; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

2.  Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis.

Authors:  B Klaver; B Berkhout
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

3.  Reverse transcription of retroviral genomes: mutations in the terminal repeat sequences.

Authors:  L I Lobel; S P Goff
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

4.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

Review 5.  The role of avian retroviral LTRs in the regulation of gene expression and viral replication.

Authors:  G Ju; B R Cullen
Journal:  Adv Virus Res       Date:  1985       Impact factor: 9.937

6.  Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism.

Authors:  M Emerman; H M Temin
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

7.  Transcriptional interference in avian retroviruses--implications for the promoter insertion model of leukaemogenesis.

Authors:  B R Cullen; P T Lomedico; G Ju
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

8.  Sequence comparison in the crossover region of an oncogenic avian retrovirus recombinant and its nononcogenic parent: genetic regions that control growth rate and oncogenic potential.

Authors:  P N Tsichlis; L Donehower; G Hager; N Zeller; R Malavarca; S Astrin; A M Skalka
Journal:  Mol Cell Biol       Date:  1982-11       Impact factor: 4.272

9.  Location and function of retroviral and SV40 sequences that enhance biochemical transformation after microinjection of DNA.

Authors:  P A Luciw; J M Bishop; H E Varmus; M R Capecchi
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

10.  Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.

Authors:  S F Yu; T von Rüden; P W Kantoff; C Garber; M Seiberg; U Rüther; W F Anderson; E F Wagner; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  48 in total

1.  Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

Review 2.  Molecular mechanisms of HIV latency.

Authors:  Daniele C Cary; Koh Fujinaga; B Matija Peterlin
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

3.  The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4.

Authors:  Ignacio J Juncadella; Renu Garg; Tonya C Bates; Elias R Olivera; Juan Anguita
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

4.  The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle.

Authors:  A T Das; B Klaver; B Berkhout
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

5.  The BARE-1 retrotransposon is transcribed in barley from an LTR promoter active in transient assays.

Authors:  A Suoniemi; A Narvanto; A H Schulman
Journal:  Plant Mol Biol       Date:  1996-05       Impact factor: 4.076

6.  Focus formation: a cell-based assay to determine the oncogenic potential of a gene.

Authors:  Angel Alvarez; Gustavo A Barisone; Elva Diaz
Journal:  J Vis Exp       Date:  2014-12-31       Impact factor: 1.355

7.  Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.

Authors:  K Verhoef; R W Sanders; V Fontaine; S Kitajima; B Berkhout
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains.

Authors:  B Berkhout; K Verhoef; J L van Wamel; N K Back
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  RNA structure modulates splicing efficiency at the human immunodeficiency virus type 1 major splice donor.

Authors:  Truus E M Abbink; Ben Berkhout
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

10.  Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription.

Authors:  Manuela Vanti; Edurne Gallastegui; Iñaki Respaldiza; Alfonso Rodríguez-Gil; Fernando Gómez-Herreros; Silvia Jimeno-González; Albert Jordan; Sebastián Chávez
Journal:  PLoS Genet       Date:  2009-01-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.